Literature DB >> 3931525

Antituberculosis activity of ofloxacin (DL 8280) on experimental tuberculosis in mice.

M Tsukamura.   

Abstract

Ofloxacin (DL 8280) is rapidly eliminated from mouse organs. It disappears quickly from the lungs and the spleen and more slowly from the liver and the kidneys. The antituberculosis activity of this agent was shown in mice when the agent was given intraperitoneally at daily doses of 1 mg per mouse (approximately 42 mg/kg). The number of viable bacteria of Mycobacterium tuberculosis strain H37Rv contained in the liver decreased markedly in the mice treated with ofloxacin, and the inhibitory effect of the agent seemed to appear when the tubercle bacilli actively multiplied.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931525     DOI: 10.1164/arrd.1985.132.4.915

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  7 in total

Review 1.  Mycobacteria and the new quinolones.

Authors:  D C Leysen; A Haemers; S R Pattyn
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

2.  Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.

Authors:  D Herbert; C N Paramasivan; P Venkatesan; G Kubendiran; R Prabhakar; D A Mitchison
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

Review 3.  New drugs and regimens for treatment of TB.

Authors:  Eric Leibert; William N Rom
Journal:  Expert Rev Anti Infect Ther       Date:  2010-07       Impact factor: 5.091

4.  In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a.

Authors:  H Saito; H Tomioka; K Sato; S Dekio
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

5.  Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice.

Authors:  V Lalande; C Truffot-Pernot; A Paccaly-Moulin; J Grosset; B Ji
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

6.  Diffusion of oral ofloxacin (HOE 280) into human prostatic tissue: assessment by an improved high-performance liquid chromatographic method.

Authors:  R Claes; Y Dusart; J C Dupont; B Jeanbaptiste; M Podoor; J Douchamps
Journal:  Infection       Date:  1986       Impact factor: 3.553

Review 7.  Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Monk; D M Campoli-Richards
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.